Donepezil in vascular dementia: a viewpoint by David S. Geldmacher.

Suppr

超能文献

作者信息

Geldmacher David S

机构信息

Department of Neurology, University of Virginia Health System, Charlottesville, Virginia, USA.

出版信息

Drugs Aging. 2003;20(15):1137. doi: 10.2165/00002512-200320150-00006.

DOI:10.2165/00002512-200320150-00006

PMID:14651436

Abstract

摘要

相似文献

Donepezil in vascular dementia: a viewpoint by David S. Geldmacher.

Drugs Aging. 2003;20(15):1137. doi: 10.2165/00002512-200320150-00006.

Donepezil in vascular dementia: a viewpoint by Gustavo C. Román.

Drugs Aging. 2003;20(15):1137-8. doi: 10.2165/00002512-200320150-00007.

Donepezil in vascular dementia: a viewpoint by Sandra E. Black.

Drugs Aging. 2003;20(15):1138. doi: 10.2165/00002512-200320150-00008.

Donepezil minimally effective for patients with vascular dementia.

J Fam Pract. 2004 Mar;53(3):181-2.

Donepezil in the treatment of vascular dementia.

Am Fam Physician. 2004 Nov 1;70(9):1681-2.

Use of donepezil for vascular dementia: preliminary clinical experience.

J Neuropsychiatry Clin Neurosci. 1999 Spring;11(2):268-70. doi: 10.1176/jnp.11.2.268.

Donepezil for Down's syndrome.

Am J Psychiatry. 2001 Jan;158(1):143. doi: 10.1176/appi.ajp.158.1.143.

Donepezil use in the treatment of dementia associated with Down syndrome.

Arch Neurol. 2003 Feb;60(2):292; author reply 292. doi: 10.1001/archneur.60.2.292-a.

Feasibility of vascular dementia treatment with cholinesterase inhibitors.

Int J Geriatr Psychiatry. 2002 Feb;17(2):194-6. doi: 10.1002/gps.546.

The effect of donepezil treatment on cardiovascular mortality.

Clin Pharmacol Ther. 2010 Sep;88(3):335-8. doi: 10.1038/clpt.2010.98. Epub 2010 Jul 21.

引用本文的文献

Multipotent Mesenchymal Stem Cell Therapy for Vascular Dementia.

Cells. 2025 Apr 29;14(9):651. doi: 10.3390/cells14090651.

Cholinesterase inhibitors: drugs looking for a disease?

PLoS Med. 2006 Apr;3(4):e140. doi: 10.1371/journal.pmed.0030140. Epub 2006 Apr 11.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Donepezil in vascular dementia: a viewpoint by David S. Geldmacher.

Drugs Aging. 2003;20(15):1137. doi: 10.2165/00002512-200320150-00006.

Donepezil in vascular dementia: a viewpoint by Gustavo C. Román.

Drugs Aging. 2003;20(15):1137-8. doi: 10.2165/00002512-200320150-00007.

Donepezil in vascular dementia: a viewpoint by Sandra E. Black.

Drugs Aging. 2003;20(15):1138. doi: 10.2165/00002512-200320150-00008.

Donepezil minimally effective for patients with vascular dementia.

J Fam Pract. 2004 Mar;53(3):181-2.

Donepezil in the treatment of vascular dementia.

Am Fam Physician. 2004 Nov 1;70(9):1681-2.

Use of donepezil for vascular dementia: preliminary clinical experience.

J Neuropsychiatry Clin Neurosci. 1999 Spring;11(2):268-70. doi: 10.1176/jnp.11.2.268.

Donepezil for Down's syndrome.

Am J Psychiatry. 2001 Jan;158(1):143. doi: 10.1176/appi.ajp.158.1.143.

Donepezil use in the treatment of dementia associated with Down syndrome.

Arch Neurol. 2003 Feb;60(2):292; author reply 292. doi: 10.1001/archneur.60.2.292-a.

Feasibility of vascular dementia treatment with cholinesterase inhibitors.

Int J Geriatr Psychiatry. 2002 Feb;17(2):194-6. doi: 10.1002/gps.546.

The effect of donepezil treatment on cardiovascular mortality.

Clin Pharmacol Ther. 2010 Sep;88(3):335-8. doi: 10.1038/clpt.2010.98. Epub 2010 Jul 21.

引用本文的文献

Multipotent Mesenchymal Stem Cell Therapy for Vascular Dementia.

Cells. 2025 Apr 29;14(9):651. doi: 10.3390/cells14090651.

Cholinesterase inhibitors: drugs looking for a disease?

PLoS Med. 2006 Apr;3(4):e140. doi: 10.1371/journal.pmed.0030140. Epub 2006 Apr 11.